Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HEALEY ALS Platform Trial - Regimen I NUZ-001

NCT07410806 is registered in ClinicalTrials.gov with Merit E. Cudkowicz, MD as lead sponsor.

NCT NCT07410806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07410806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HEALEY ALS Platform Trial - Regimen I NUZ-001
Lead sponsor
Merit E. Cudkowicz, MD
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
February 25, 2026
Completion date
August 1, 2028
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis (als)